November 28, 2014 6:21 AM ET

Pharmaceuticals

Company Overview of Elixir Pharmaceuticals, Inc.

Company Overview

Elixir Pharmaceuticals, Inc., a pharmaceutical company, engages in the discovery, development, and commercialization of novel pharmaceuticals for the treatment of metabolic diseases. It develops small molecule drugs that mimic longevity responses, as well as used to treat a range of age-related diseases, including diabetes and obesity. The company’s products include Metgluna and Glinsuna for the treatment of type 2 diabetes; Ghrelin, an oral antagonist for the treatment of metabolic diseases; and EX-1314, an oral drug developed for the treatment of type 1 diabetic gastroparesis. It has strategic alliances/partnerships with Kissei Pharmaceuticals, Bristol-Myers Squibb, Siena Biotech S.p.A., a...

300 Putnam Avenue

Cambridge, MA 02139

United States

Founded in 1999

30 Employees

Phone:

617-995-7000

Fax:

617-995-7050

Key Executives for Elixir Pharmaceuticals, Inc.

Chief Executive Officer
Age: 60
Co-Founder
Co-Founder
Co-Founder and Vice President
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Pharmagenesis, Inc. United States
Baxter Pharmaceutical Solutions LLC United States
Hedgepath, LLC United States
Adial Pharmaceuticals, LLC United States
Biotab Nutraceuticals Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Elixir Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.